神经内分泌肿瘤椎体转移:如何利用CT模式分析避免68Ga-DOTA-TOC PET假阳性
该回顾性研究纳入535例神经内分泌肿瘤患者的68Ga-DOTA-TOC PET/CT,在79例(14.8%)中检出107个椎体转移灶、34个典型椎体血管瘤和31个其他良性病变;以生物体积≥0.72 cm3、SUVmax≥2及SUVmax比值等阈值区分转移与良性病变,病灶水平敏感度87%–99%、特异度55%–100%。
要点
- 神经内分泌肿瘤椎体转移在68Ga-DOTA-TOC PET/CT上可表现为高摄取,需与椎体血管瘤等良性病变鉴别。
- 部分椎体血管瘤可不出现典型「斑点状」CT模式,仅凭CT形态可能误判为转移。
- 联合CT特征与定量68Ga-DOTA-TOC摄取(如SUVmax比值)可提高鉴别特异度。
核心结论
- 68Ga-DOTA-TOC PET/CT检测神经内分泌肿瘤椎体转移的高敏感度得到确认,联合CT特征与定量摄取可提高特异度。
研究设计与样本
- 回顾性研究,纳入535例神经内分泌肿瘤患者,回顾其68Ga-DOTA-TOC PET/CT图像中的椎体CT病变和/或PET摄取灶,以转移、典型椎体血管瘤或其他良性病变进行分类,并测定CT表现、生物体积、SUVmax及与参考器官的比值。
关键影像表现/征象
- 部分椎体血管瘤可缺乏典型的「斑点状」CT模式,此类不典型血管瘤需借助68Ga-DOTA-TOC摄取定量与转移鉴别。
诊断标准与关键数值
- 鉴别转移与良性病变的最佳阈值:生物体积≥0.72 cm3对应病灶水平敏感度87%、特异度55%;SUVmax≥2对应敏感度98%、特异度100%;SUVmax与参考椎体比值≥2.1对应敏感度97%、特异度90%;与肝脏比值≥0.28对应敏感度99%、特异度97%;与脾脏比值≥0.14对应敏感度94%、特异度100%。
临床应用与阅片要点
- 阅片时对椎体PET高摄取灶应结合CT形态,注意部分椎体血管瘤可无典型「斑点状」表现,并参考生物体积、SUVmax及与参考椎体、肝脏、脾脏的SUVmax比值等定量指标辅助鉴别转移与良性病变。
局限性
- 原文为回顾性研究。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop criteria to improve discrimination between vertebral metastases from neuroendocrine tumours (NETs) and benign bone lesions on PET combined with CT using DOTA-D-Phe1-Tyr3-octreotide labelled with gallium-68 (68Ga-DOTA-TOC).
METHODS: In 535 NET patients, 68Ga-DOTA-TOC PET/CT examinations were reviewed retrospectively for vertebral CT lesions and/or PET foci. For each vertebral PET abnormality, appearance on CT, biological volume (BV), standardized uptake value (SUVmax) and ratios to those of reference organs were determined. All vertebral abnormalities were characterized as a metastasis, a typical vertebral haemangioma (VH) or other benign lesion.
RESULTS: In 79 patients (14.8 %), we found 107 metastases, 34 VHs and 31 other benign lesions in the spine. The optimal cut-off values to differentiate metastases from benign lesions were BV ≥0.72 cm3, SUVmax ≥2, SUVmax ratio to a reference vertebra ≥2.1, to liver ≥0.28 and to spleen ≥0.14. They corresponded to lesion-based 68Ga-DOTA-TOC PET/CT sensitivity of 87 %, 98 %, 97 %, 99 % and 94 %, and specificity of 55 %, 100 %, 90 %, 97 %, 100 %, respectively.
CONCLUSIONS: The high sensitivity of 68Ga-DOTA-TOC-PET/CT in detecting NET vertebral metastases was confirmed; this study showed that specificity could be improved by combining CT features and quantifying 68Ga-DOTA-TOC uptake.
KEY POINTS: • Bone metastases in neuroendocrine tumours correlate with prognosis. • Benign bone lesions may mimic metastases on 68 Ga-DOTA-TOC PET/CT imaging. • The specific polka-dot CT pattern may be missing in some vertebral haemangiomas. • Lesion atypical for haemangiomas can be better characterized by quantifying 68 Ga-DOTA-TOC uptake.
引用
- Gauthé M, Testart Dardel N, Ruiz Santiago F, et al. Vertebral metastases from neuroendocrine tumours: How to avoid false positives on 68Ga-DOTA-TOC PET using CT pattern analysis? Eur Radiol. 2018. PMID: 29532242. doi:10.1007/s00330-017-5294-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。